Jørgen Nyhus

HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)

Anne‐Marte Bakken Kran, Birger Sørensen, Jørgen Nyhus et al. · AIDS · 2004 · 49 citations

Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral Therapy

Birgitta Åsjö, Helen Stavang, Birger Sørensen et al. · AIDS Research and Human Retroviruses · 2002 · 42 citations

Vaccination, Antiretroviral Therapy, Allergy +14

A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection

Nils Grude, Andrew Jenkins, Linda M. Strand et al. · Clinical Microbiology and Infection · 2006 · 41 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +11

Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization

Anne‐Marte Bakken Kran, Maja A. Sommerfelt, Birger Sørensen et al. · Vaccine · 2005 · 31 citations

Primary Immunodeficiency, Viral Burden, High Responder Patients +8

Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread

Nils Grude, Linda M. Strand, HILDE‐CHRISTINE MYKLAND et al. · Clinical Microbiology and Infection · 2008 · 21 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +10